+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations



Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations



Brain Research 855(1): 158-161



Inositol uptake was measured at concentrations of 25, 40 and 50 muM in human astrocytoma cell cultures treated for 1-3 weeks with pharmacologically relevant concentrations of LiCl, valproic acid or carbamazepine as well as in control cultures that had not been treated with any drug. After at least 2 weeks of treatment, each of these 3 conventional anti-bipolar drugs increased the uptake significantly at 25 muM inositol, had no effect at 40 muM, and decreased it at 50 muM inositol. Reduction of the drug concentrations by 50% abolished the stimulation of uptake at 25 muM inositol by lithium and valproic acid and reduced that by carbamazepine. These findings may contribute to an understanding of the mechanisms of action for anti-bipolar medication, and explain the controversy in the literature whether or not brain inositol is reduced after chronic administration of lithium.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010322735

Download citation: RISBibTeXText

PMID: 10650143

DOI: 10.1016/s0006-8993(99)02371-9


Related references

Effects of single and repeated doses of lithium on brain regional inositol inositol 1 phosphate and calcium concentrations. Society for Neuroscience Abstracts 15(1): 657, 1989

High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium. Pharmacology Biochemistry and Behavior 49(2): 341-343, 1994

Lithium increases accumulation of inositol 1 4 5 trisphosphate and inositol 1 3 4 5 tetrakisphosphate in cholinergically stimulated brain cortex slices in guinea pig mouse and rat the increases require inositol supplementation in mouse and rat but not in guinea pig. Biochemical Journal 282(2): 377-385, 1992

Studies on myo inositol 1 phosphatase suggest that the large increases in rat brain inositol 1 phosphate that result from lithium treatment are due mainly to phosphatidylinositol metabolism. Federation Proceedings 45(6): 1826, 1986

Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients. Neuropsychopharmacology 19(3): 220-232, 1998

Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS. Biological Psychiatry 40(4): 235-246, 1996

Chronic treatment with lithium and pretreatment with excess inositol reduce inositol pool size in astrocytes by different mechanisms. Brain Research. 787(1): 34-40, Ch 16, 1998

Lithium stimulates accumulation of second-messenger inositol 1,4,5-trisphosphate and other inositol phosphates in mouse pancreatic minilobules without inositol supplementation. Biochemical Journal 304: 251-258, 1994

The dephosphorylation of inositol 1 4 bisphosphate to inositol in liver and brain involves two distinct lithium sensitive enzymes and proceeds via inositol 4 phosphate. Biochemical Journal 249(1): 143-148, 1988

Inositol phosphate phosphatases of microbiological origin inositol phosphate intermediates in the dephosphorylation of the hexa phosphates of myo inositol scyllo inositol and d chiro inositol by a bacterial pseudomonas sp phytase. Australian Journal of Biological Sciences 23(6): 1207-1220, 1970

Inositol phosphate phosphatases of microbiological origin. Inositol phosphate intermediates in the dephosphorylation of the hexaphosphates of myo-inositol, scyllo-inositol, and D-chiro-inositol by a bacterial (Pseudomonas sp.) phytase. Australian Journal of Biological Sciences 23(6): 1207-1220, 1970

Inositol phosphate phosphatases of microbiological origin. inositol phosphate intermediates in the dephosphorylation of the hexaphosphates of myo-inositol, scyllo-inositol, and D-chrio-inositol by a bacterial (Pseudomonas sp.) phytase. 1970

Isolation and separation of inositol 1 phosphate cyclic inositol 1 2 phosphate and glyceryl phospho inositol from tissue culture cells labeled with tritiated inositol. Hoppe Seyler's Zeitschrift fuer Physiologische Chemie 358(3): 367-375, 1977

Diabetes-induced increases in vascular permeability and changes in granulation tissue levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinil. Metabolism: Clinical and Experimental 35(4 Suppl 1): 41-45, 1986

Inositol and inositol 1,4,5-trisphosphate content of Down syndrome fibroblasts exhibiting enhanced inositol uptake. Febs Letters 295(1-3): 43-47, 1991